Sonnet Biotherapeutics Holdings Inc (NASDAQ:SONN)
| 0.502 Delayed Data As of 3:58pm ET |  +0.0057 / +1.15%Today’s Change | 0.21 Today|||52-Week Range 4.56 | -56.35% Year-to-Date |
Latest SONN News | Press Releases
No recent news for Sonnet Biotherapeutics Holdings Inc.
Today’s Trading
| Previous close | 0.50 |
| Today’s open | 0.51 |
| Day’s range | 0.46 - 0.54 |
| Volume | 58,607 |
| Average volume (3 months) | 2,015,232 |
| Market cap | $11.9M |
Data as of 3:58pm ET, 05/31/2023
Growth & Valuation
| Earnings growth (last year) | +52.03% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | -27.64% |
| P/E ratio | NM |
| Price/Sales | 18.27 |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Last reporting date | May 31, 2023 |
| EPS forecast (this quarter) | -$0.45 |
| Annual revenue (last year) | $349.9K |
| Annual profit (last year) | -$29.7M |
| Net profit margin | -8,493.34% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
